| 1 |
Riquet M，Arame A，Le Pimpec Barthes F．Non-small cell lung cancer invading the chest wall[J]．Thorac Surg Clin，2010，20（4）：519-527．
|
| 2 |
Wang L，Yan X，Zhao J，et al．Expert consensus on resection of chest wall tumors and chest wall reconstruction[J]．Transl Lung Cancer Res，2021，10（11）：4057-4083．
|
| 3 |
Yokoi K，Taniguchi T，Usami N，et al．Surgical management of locally advanced lung cancer[J]．Gen Thorac Cardiovasc Surg，2014，62（9）：522-530．
|
| 4 |
Downey RJ，Martini N，Rusch VW，et al．Extent of chest wall invasion and survival in patients with lung cancer[J]．Ann Thorac Surg，1999，68（1）：188-193．
|
| 5 |
仲佳．《CSCO非小细胞肺癌诊疗指南2021》更新要点解读[J]．实用肿瘤杂志，2022，37（1）：8-15．
|
| 6 |
Ucvet A，Yazgan S，Gursoy S，et al．Prognosis of Resected Non-small Cell Lung Cancer with Ipsilateral Pulmonary Metastasis[J]．Thorac Cardiovasc Surg，2020，68（2）：176-182．
|
| 7 |
Lee CY，Byun CS，Lee JG，et al．The prognostic factors of resected non-small cell lung cancer with chest wall invasion[J]．World J Surg Oncol，2012，10：9．
|
| 8 |
Suzuki M，Yoshida S，Moriya Y，et al．Surgical outcomes of newly categorized peripheral T3 non-small cell lung cancers: comparisons between chest wall invasion and large tumors （>7 cm）[J]．Interact Cardiovasc Thorac Surg，2010，11（4）：420-424．
|
| 9 |
Voltolini L，Rapicetta C，Luzzi L，et al．Lung cancer with chest wall involvement: predictive factors of long-term survival after surgical resection[J]．Lung Cancer，2006，52（3）：359-364．
|
| 10 |
Coster JN，Groth SS．Surgery for Locally Advanced and Oligometastatic Non-Small Cell Lung Cancer[J]．Surg Oncol Clin N Am，2020，29（4）：543-554．
|
| 11 |
Facciolo F，Cardillo G，Lopergolo M，et al．Chest wall invasion in non-small cell lung carcinoma：a rationale for en bloc resection[J]．J Thorac Cardiovasc Surg，2001，121（4）：649-656．
|
| 12 |
Otsuka S，Hiraoka K，Ohtaka K，et al．Small-sized peripheral squamous cell lung carcinoma with chest wall invasion[J]．Respir Med Case Rep，2022，36：101589．
|
| 13 |
Santos HT，Lopes AJ，Higa C，et al．Lung cancer with chest wall invasion：retrospective analysis comparing en-bloc resection and 'resection in bird cage’[J]．J Cardiothorac Surg，2014，9：57．
|
| 14 |
Doddoli C，D’Journo B，Le Pimpec-Barthes F，et al．Lung cancer invading the chest wall: a plea for en-bloc resection but the need for new treatment strategies[J]．Ann Thorac Surg，2005，80（6）：2032-2040．
|
| 15 |
Hanagiri T，Shinohara S，Takenaka M，et al．Clinical Characteristics of Resected T3 Non-small Cell Lung Cancer Characterized by Parietal Pleural Invasion or Chest Wall Invasion[J]．Indian J Surg，2014，76（5）：354-358．
|
| 16 |
Akata S，Kajiwara N，Park J，et al．Evaluation of chest wall invasion by lung cancer using respiratory dynamic MRI[J]．J Med Imaging Radiat Oncol，2008，52（1）：36-39．
|
| 17 |
Tahiri M，Khereba M，Thiffault V，et al．Preoperative assessment of chest wall invasion in non-small cell lung cancer using surgeon-performed ultrasound[J]．Ann Thorac Surg，2014，98（3）：984-989．
|
| 18 |
Sripathi S，Mahajan A．Comparative study evaluating the role of color Doppler sonography and computed tomography in predicting chest wall invasion by lung tumors[J]．J Ultrasound Med，2013，32（9）：1539-1546．
|
| 19 |
Collaud S，Fadel E，Schirren J，et al．En Bloc Resection of Pulmonary Sulcus Non-small Cell Lung Cancer Invading the Spine: A Systematic Literature Review and Pooled Data Analysis[J]．Ann Surg，2015，262（1）：184-188．
|
| 20 |
Jones GD，Caso R，No JS，et al．Prognostic factors following complete resection of non-superior sulcus lung cancer invading the chest wall[J]．Eur J Cardiothorac Surg，2020，58（1）：78-85．
|
| 21 |
王磊，李靖，钟代星．胸壁肿瘤切除及胸壁重建手术中国专家共识(2018版)[J]．中国胸心血管外科临床杂志，2019，26（1）：1-7．
|
| 22 |
Kawaguchi K，Mori S，Usami N，et al．Preoperative evaluation of the depth of chest wall invasion and the extent of combined resections in lung cancer patients[J]．Lung Cancer，2009，64（1）：41-44．
|
| 23 |
张茂增，胡为才，姬弘涛．胸壁切除术和非胸壁切除术治疗非小细胞肺癌的效果对比[J]．右江民族医学院学报，2020，42（2）：212-215．
|
| 24 |
陈重．侵犯胸壁的非小细胞肺癌的外科治疗[J]．河南医学研究，2012，21（3）：285-286．
|
| 25 |
Scarnecchia E，Liparulo V，Capozzi R，et al．Chest wall resection and reconstruction for tumors: analysis of oncological and functional outcome[J]．J Thorac Dis，2018，10（Suppl 16）：S1855-S1863．
|
| 26 |
Lanuti M．Surgical Management of Lung Cancer Involving the Chest Wall[J]．Thorac Surg Clin，2017，27（2）：195-199．
|
| 27 |
Matsuoka H，Nishio W，Okada M，et al．Resection of chest wall invasion in patients with non-small cell lung cancer[J]．Eur J Cardiothorac Surg，2004，26（6）：1200-1204．
|
| 28 |
Magdeleinat P，Alifano M，Benbrahem C，et al．Surgical treatment of lung cancer invading the chest wall: results and prognostic factors[J]．Ann Thorac Surg，2001，71（4）：1094-1099．
|
| 29 |
Berry MF，Onaitis MW，Tong BC，et al．Feasibility of hybrid thoracoscopic lobectomy and en-bloc chest wall resection[J]．Eur J Cardiothorac Surg，2012，41（4）：888-892．
|
| 30 |
Demmy TL，Yendamuri S，Hennon MW，et al．Thoracoscopic maneuvers for chest wall resection and reconstruction[J]．J Thorac Cardiovasc Surg，2012，144（3）：S52-S57．
|
| 31 |
Muguruza I，Aranda JL，García-Yuste M．Treatment of lung cancer with chest wall invasion[J]．Arch Bronconeumol，2011，47 Suppl 1：27-32．
|
| 32 |
Zhang Y，Li JZ，Hao YJ，et al．Sternal tumor resection and reconstruction with titanium mesh：a preliminary study[J]．Orthop Surg，2015，7（2）：155-160．
|
| 33 |
Weyant MJ，Bains MS，Venkatraman E，et al．Results of chest wall resection and reconstruction with and without rigid prosthesis[J]．Ann Thorac Surg，2006，81（1）：279-285．
|
| 34 |
Scarnecchia E，Liparulo V，Capozzi R，et al．Chest wall resection and reconstruction for tumors: analysis of oncological and functional outcome[J]．J Thorac Dis，2018，10（Suppl 16）：S1855-S1863．
|
| 35 |
Wiegmann B，Zardo P，Dickgreber N，et al．Biological materials in chest wall reconstruction: initial experience with the Peri-Guard Repair Patch[J]．Eur J Cardiothorac Surg，2010，37（3）：602-605．
|
| 36 |
Wang L，Huang L，Li X，et al．Three-Dimensional Printing PEEK Implant: A Novel Choice for the Reconstruction of Chest Wall Defect[J]．Ann Thorac Surg，2019，107（3）：921-928．
|
| 37 |
Kumar N，Malik PS，Bharati SJ，et al．Primary lung cancer with chest wall involvement: Outcomes of a multimodality management approach[J]．Lung India，2021，38（4）：338-342．
|
| 38 |
Sauerbier M，Dittler S，Kreutzer C．Microsurgical chest wall reconstruction after oncologic resections[J]．Semin Plast Surg，2011，25（1）：60-69．
|
| 39 |
Brown LM，Cooke DT，David EA．Adjuvant Chemotherapy Does Not Improve Survival for Lung Cancer With Chest Wall Invasion[J]．Ann Thorac Surg，2017，104（6）：1798-1804．
|
| 40 |
Berriochoa C，Videtic GM，Woody NM，et al．Stereotactic Body Radiotherapy for T3N0 Lung Cancer With Chest Wall Invasion[J]．Clin Lung Cancer，2016，17（6）：595-601．
|
| 41 |
Muñoz-Largacha JA，Rao SR，Brinckerhoff LH，et al．Induction chemoradiation is associated with improved survival in chest wall invasion lung cancer[J]．Tumori，2019，105（4）：331-337．
|
| 42 |
Kennedy WR，Gabani P，Nikitas J，et al．Treatment of T3N0 non-small cell lung cancer with chest wall invasion using stereotactic body radiotherapy[J]．Clin Transl Radiat Oncol，2019，16：1-6．
|
| 43 |
Stoelben E，Ludwig C．Chest wall resection for lung cancer: indications and techniques[J]．Eur J Cardiothorac Surg，2009，35（3）：450-456．
|
| 44 |
Wang Meina，Herbst Roy S.，Boshoff Chris，等．非小细胞肺癌的个体化治疗进展[J]．中国肺癌杂志，2022，25（3）：219-236．
|
| 45 |
Zhong WZ，Chen KN，Chen C，et al．Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 EGFR-Mutant Non-Small-Cell Lung Cancer （EMERGING-CTONG 1103）：A Randomized Phase II Study[J]．J Clin Oncol，2019，37（25）：2235-2245．
|
| 46 |
Liu SY，Zhang JT，Zeng KH，et al．Perioperative targeted therapy for oncogene-driven NSCLC[J/OL]．Lung Cancer，2022，[Epub ahead of print]．
|
| 47 |
Sun L，Guo YJ，Song J，et al．Neoadjuvant EGFR-TKI Therapy for EGFR-Mutant NSCLC：A Systematic Review and Pooled Analysis of Five Prospective Clinical Trials[J]．Front Oncol，2020，10：586596．
|
| 48 |
Zhao Z，Gao Y，Xue Q，et al．Safety and Efficacy of Neoadjuvant Immune Checkpoint Inhibitor Therapy in Patients with Resectable Non-small-Cell Lung Cancer：A Systematic Review[J]．Target Oncol，2021，16（4）：425-434．
|
| 49 |
Yeh J，Marrone KA，Forde PM．Neoadjuvant and consolidation immuno-oncology therapy in stage III non-small cell lung cancer[J]．J Thorac Dis，2018，10（Suppl 3）：S451-S459．
|
| 50 |
Wang J，Li J，Cai L，et al．The safety and efficacy of neoadjuvant programmed death 1 inhibitor therapy with surgical resection in stage IIIA non-small cell lung cancer[J]．Ann Transl Med，2021，9（6）：486．
|
| 51 |
Janjigian YY，Shitara K，Moehler M，et al．First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma （CheckMate 649）: a randomised, open-label, phase 3 trial[J]．Lancet，2021，398（10294）：27-40．
|
| 52 |
Douillard JY，Rosell R，De Lena M，et al．Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial[J]．Int J Radiat Oncol Biol Phys，2008，72（3）：695-701．
|
| 53 |
Le Pechoux C，Pourel N，Barlesi F，et al．Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART)：an open-label, randomised, phase 3 trial[J]．Lancet Oncol，2022，23（1）：104-114．
|
| 54 |
朱晓霞，苏俊威．精确术后放疗对pⅢA-N2非小细胞肺癌患者在完全切除和辅助化疗后生存和失败模式的影响[J]．循证医学，2020，20（6）：325-328．
|
| 55 |
Gao SJ，Corso CD，Blasberg JD，et al．Role of Adjuvant Therapy for Node-Negative Lung Cancer Invading the Chest Wall[J]．Clin Lung Cancer，2017，18（2）：169-177.e4．
|
| 56 |
Yue D，Xu S，Wang Q，et al．Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer （EVAN）:a randomised, open-label, phase 2 trial[J]．Lancet Respir Med，2018，6（11）：863-873．
|
| 57 |
Chen CY，Fares CM，Shin DS．Osimertinib as neoadjuvant therapy in a patient with stage IIIA non-small cell lung cancer: a case report[J]．J Med Case Rep，2021，15（1）：216．
|
| 58. |
Felip E，Altorki N，Zhou C，et al．Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer （IMpower010）：a randomised, multicentre, open-label, phase 3 trial[J]．Lancet，2021，398（10308）：1344-1357．
|